Continuous positive airway pressure in premature infants with respiratory distress syndrome
Phase 1
- Conditions
- respiratory distress syndrome of preterm neonates.Respiratory distress syndrome of newborn
- Registration Number
- IRCT2014032716870N2
- Lead Sponsor
- Shahid Sadoughi University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 40
Inclusion Criteria
Infants with a gestational age of 28 to 34 weeks with respiratory distress syndrome
Exclusion criteria:
Life-threatening congenital malformations
Severe asphyxia
Sepsis
hematocrit less than 35
Intracranial hemorrhage and intraventricular hemorrhage grade three or four
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Duration of mechanical ventilation. Timepoint: daily. Method of measurement: Registration time day.
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What are the molecular mechanisms by which bubble CPAP improves surfactant distribution in preterm infants with RDS?
How does bubble CPAP compare to standard CPAP in reducing mechanical ventilation use for preterm RDS infants?
Which biomarkers correlate with improved oxygenation in preterm infants receiving CPAP for respiratory distress syndrome?
What are the adverse event profiles of bubble CPAP versus standard CPAP in preterm RDS infants?
What are the primary clinical endpoints in IRCT2014032716870N2 for bubble CPAP in preterm RDS infants?